UPDATE: With Multimedia: U.S. FDA Approves ELIQUIS® (apixaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

View Full Size 

Download

• Full Size JPEG, 688x375, 130.6 KB
• Small JPEG, 480x262, 89.0 KB
• Preview JPEG, 144x78, 17.8 KB
• Thumbnail JPEG, 120x65, 14.1 KB